Moderna Stock Rises on New Product Pipeline as Inflation Edges Up
- Moderna's stock price increased based on positive vaccine news and plans to expand product offerings over the next 5 years.
- China presents stock investment opportunities in internet, insurance, sportswear, and solar companies like Alibaba.
- Inflation rose 3.7% in August, with gas prices up but core categories slowing.
- Cash holdings among fund managers have dropped, affecting markets.
- The ECB is expected to keep interest rates on hold, similar to the Fed's approach.